Table 1.
T cell subpopulation | Alterations compared with | References | |
---|---|---|---|
Healthy control | Other CKD as a control | ||
Th1 | |||
% in PBL | ↓/N | n.d. | [15, 16] |
IFN-γ | ↓/↑ | n.d. | [15, 29, 78] |
IL-2 | ↑ | n.d. | [29, 78] |
Th2 | |||
% in PBL | ↑ | n.d. | [15] |
IL-4 | ↑ | n.d. | [29, 78] |
IL-5 | ↑ | n.d. | [15] |
IL-6 | ↑ | n.d | [13] |
Th17 | |||
% in PBL | ↑ | ↑ | [13–16] |
IL-17A | ↑ | n.d. | [13, 15, 18, 29, 78] |
Th22 | |||
% in PBL | ↑ | ↑ | [14, 16] |
IL-22 | ↑ | ↑ | [14] |
Tfh | |||
% in PBL | ↑ | n.d. | [17] |
IL-21 | ↑ | n.d. | [13, 17, 78] |
Tc | |||
% in PBL | N | n.d | [62] |
Treg | |||
Treg % in PBL | ↓ | n.d | [15, 19] |
Activated Treg % in PBL | ↓ | n.d. | [13] |
Resting Treg % in PBL | N | n.d. | [13] |
iTreg % in PBL | ↓ | n.d. | [18] |
nTreg % in PBL | N | n.d. | [18] |
IL-10 | ↓/↑ | n.d. | [13, 15, 18, 29, 78] |
TGF-β1 | ↑/N/↓ | n.d. | [13, 18, 32] |
γδ T cells | |||
% in PBL | ↑ | n.d. | [20] |
Disagreement in literature was shown using slash
CKD chronic kidney disease, PBL peripheral blood lymphocytes, ↑ increased versus control, ↓ decreased versus control, N unchanged versus control